Familial Mediterranean Fever and Transverse Myelitis: A Causal Relation?

Overview

Journal Neurol Ther

Publisher Springer

Specialty Neurology

Date 2023 Mar 8

PMID 36884138

Authors

Ali Motahharynia

Ghazaal Alavi Tabatabaei

Reza Sarrafi

Saba Naghavi

Iman Adibi

Affiliations

Soon will be listed here.

Abstract

Familial Mediterranean fever (FMF) is a rare autoinflammatory disorder characterized mainly by recurrent self-limited episodes of fever and polyserositis. FMF-related neurologic complication is an old debate, and the correlation between FMF and demyelinating disorders has been a matter of dispute for a long time. Few reports demonstrated a relationship between FMF and multiple sclerosis; however, the existence of a causal relationship between FMF and demyelinating disorders is still a puzzle. This report presents the first case of transverse myelitis following FMF attacks in which neurologic manifestations were resolved using colchicine treatment. Due to relapses of FMF, which were accompanied by transverse myelitis, rituximab was administered, which resulted in stabilizing disease activity. Accordingly, in the case of colchicine-resistant FMF and FMF-related demyelinating conditions, rituximab could be considered as a potential therapeutic option to alleviate both polyserositis and demyelinating manifestations.

References

Pozzato M, Micaglio E, Cucuzza C, Cagol A, Galimberti D, Calandrella D . Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis. Front Neurol. 2021; 11:591395. PMC: 7874168. DOI: 10.3389/fneur.2020.591395. View

Ozturk B . Familial Mediterranean Fever and Multiple Sclerosis Successfully Treated With Interferon Beta-1a: A Case Report. Arch Rheumatol. 2020; 34(4):443-446. PMC: 6974384. DOI: 10.5606/ArchRheumatol.2019.7249. View

Wu B, Xu T, Li Y, Yin X . Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev. 2018; 10:CD010893. PMC: 6517233. DOI: 10.1002/14651858.CD010893.pub3. View

Kemanetzoglou E, Andreadou E . CNS Demyelination with TNF-α Blockers. Curr Neurol Neurosci Rep. 2017; 17(4):36. PMC: 5364240. DOI: 10.1007/s11910-017-0742-1. View

Alpayci M, Bozan N, Erdem S, Gunes M, Erden M . The possible underlying pathophysiological mechanisms for development of multiple sclerosis in familial Mediterranean fever. Med Hypotheses. 2012; 78(6):717-20. DOI: 10.1016/j.mehy.2012.02.017. View

Demir C, Balgetir F, Ethemoglu O, Aksoy D, Aktas F, Koca S . Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis. Arch Rheumatol. 2021; 36(2):219-226. PMC: 8418767. DOI: 10.46497/ArchRheumatol.2021.8229. View

Atas N, Armagan B, Bodakci E, Satis H, Sari A, Bilge N . Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study. Rheumatol Int. 2019; 40(1):41-48. DOI: 10.1007/s00296-019-04412-7. View

Ozdogan H, Ugurlu S, Uygunoglu U, Tutuncu M, Gul A, Akman G . The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis. Mult Scler Relat Disord. 2020; 45:102332. DOI: 10.1016/j.msard.2020.102332. View

Elhani I, Dumont A, Vergneault H, Ardois S, Le Besnerais M, Levesque H . Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review. Mult Scler Relat Disord. 2021; 50:102834. DOI: 10.1016/j.msard.2021.102834. View

10.

Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, Flechter S . Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol. 2011; 18(9):1146-50. DOI: 10.1111/j.1468-1331.2011.03356.x. View

11.

Lindahl H, Bryceson Y . Neuroinflammation Associated With Inborn Errors of Immunity. Front Immunol. 2022; 12:827815. PMC: 8807658. DOI: 10.3389/fimmu.2021.827815. View

12.

Sangiorgi E, Rigante D . The Clinical Chameleon of Autoinflammatory Diseases in Children. Cells. 2022; 11(14). PMC: 9318468. DOI: 10.3390/cells11142231. View

13.

Kalyoncu U, Eker A, Oguz K, Kurne A, Kalan I, Topcuoglu A . Familial Mediterranean fever and central nervous system involvement: a case series. Medicine (Baltimore). 2010; 89(2):75-84. DOI: 10.1097/MD.0b013e3181d5dca7. View

14.

Kuemmerle-Deschner J, Gautam R, George A, Raza S, Lomax K, Hur P . A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever. Rheumatology (Oxford). 2020; 59(10):2711-2724. DOI: 10.1093/rheumatology/keaa205. View

15.

Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge A . Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?. J Neurol. 2006; 253(7):928-34. DOI: 10.1007/s00415-006-0137-8. View